iMTA report, Erasmus University Rotterdam. Evaluation Report to National Health Insurance Board. 'Cost-effectiveness of Entecavir as Antiviral therapy in Hepatitis.'

LW Niessen

iMTA report, Erasmus University Rotterdam. Evaluation Report to National Health Insurance Board. 'Cost-effectiveness of Entecavir as Antiviral therapy in Hepatitis.'

LW Niessen

Research output: Working paper

Original language	English
Publication status	Published - 2015

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

TY - UNPB

T1 - iMTA report, Erasmus University Rotterdam. Evaluation Report to National Health Insurance Board. 'Cost-effectiveness of Entecavir as Antiviral therapy in Hepatitis.'

AU - Niessen, LW

PY - 2015

Y1 - 2015

M3 - Working paper

BT - iMTA report, Erasmus University Rotterdam. Evaluation Report to National Health Insurance Board. 'Cost-effectiveness of Entecavir as Antiviral therapy in Hepatitis.'

ER -